A postdoctoral training position is available in the Committee on the Neurobiology of Addictive Disorders
(http://www.scripps.edu/research/cnad/) at The Scripps Research Institute (www.scripps.edu). The trainee will benefit from a vibrant research environment in CNAD which houses the laboratories of multiple investigators focused on topics related to substance abuse. The Taffe laboratory will serve as the primary training environment but collaborative work with one or more of our ongoing collaborators is expected. Current projects in the laboratory focus on the reinforcing, addictive and toxic effects of psychomotor stimulants, including novel cathinone derivatives, of the exogenous cannabinoids/cannabimimetics and of prescription opioids in rodent models. In addition to basic behavioral and neurobiological consequences, the group investigates the potential of anti-drug vaccination and/or physical exercise to moderate drug effects.
Applicants should have a recent doctoral degree in neuroscience, behavioral pharmacology, experimental psychology or related field and a strong interest in substance abuse research. An ability to think critically and creatively, along with strong writing and communication skills is essential. Previous experience with /in vivo/ rodent models is preferred, but not essential. Applications will be accepted until the position is filled. /The Scripps Research Institute is an equal opportunity employer and individuals underrepresented in the field are especially encouraged to apply./
Please send a cover letter, CV and contact information for three references to Dr. Taffe (mtaffe@scripps.edu).
--
Michael A. Taffe, Ph.D.
Associate Professor
Committee on the Neurobiology of Addictive Disorders Mailcode SP30-2400 The Scripps Research Institute
10550 North Torrey Pines Road
La Jolla CA 92037
ph. 858.784.7228; fax: 858.784.7405
http://www.scripps.edu/cnad/taffe/
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org
No comments:
Post a Comment